Skip to content
Clinical Trials – home
Rare disease

Neuroblastoma recurrent

  • 1 clinical trial
  • 5 countries
Quick filters

1 Clinical trial

Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Naxitamab
  • Sponsor:Y-mAbs Therapeutics A/S
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.